Model predictive control has become an increasingly popular control strategy thanks to the ability to handle constrained systems. Obtaining the required models through system identification is often a time consuming and costly process. Applications oriented experiment design is a means of reducing this effort but is often formulated in terms of the input's spectral properties. Therefore, time domain constraints are difficult to enforce. In this contribution we combine MPC with experiment design to formulate a control problem where excitation constraints are included. The benefits are that time domain constraints are respected while the experiment design criteria are fulfilled. The method is evaluated on a numerical example.
Abstract-This paper considers the problem of realizing an input signal with a desired autocorrelation sequence satisfying both input and output constraints for the system it is to be applied to. This is a important problem in system identification. Firstly, the properties of the identified model are highly dependent on the used excitation signal during the experiment and secondly, on real processes, due to actuator saturation and safety considerations, it is important to constrain the inputs and outputs of the process. The proposed method is formulated as a nonlinear model predictive control problem. In general this corresponds to solving a non-convex optimization problem. Here we show how this can be solved in one particular case. For this special case convergence is established for generation of pseudo-white noise. The performance of the algorithm is successfully verified by simulations for a few different autocorrelation sequences, with and without input and output constraints.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.